{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:31:13Z","timestamp":1786739473966,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Neurological involvement after coronavirus disease (COVID-19) pneumonias is common and occurs in almost one-third of the patients. The commonest neurological symptoms are ageusia, anosmia, headache, nausea, vomiting, dizziness, and myalgia. Guillain\u2013Barre syndrome (GBS) is a rare manifestation of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection; whereas the common neurological manifestations of the SARS-CoV-2 infection occur with the onset of the respiratory symptoms and may be due to the direct invasion of the nervous system by the virus, GBS in COVID-19 follows a time lag of 1\u20134 weeks and may be attributable to the immune mechanism of molecular mimicry. Here we report a case of GBS in a patient of COVID-19 which occurred on the 22\n                      <jats:sup>nd<\/jats:sup>\n                      day after the onset of the disease. The patient recovered completely and went home walking.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2454_20","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T11:10:32Z","timestamp":1627557032000},"page":"2706-2708","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Getting paralysed after COVID"],"prefix":"10.4103","volume":"10","author":[{"given":"Sameer K.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-44-20240828","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"R2-44-20240828","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","article-title":"Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: An instant systematic review of the first six months of pandemic","volume":"91","author":"Uncini","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R3-44-20240828","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nmd.2020.08.354","article-title":"Guillain-Barr\u00e9-Strohl syndrome and COVID-19: Case report and literature review","volume":"30","author":"Diez-Porras","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"R4-44-20240828","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe COVID-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-44-20240828","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","article-title":"Guillain-Barre syndrome during COVID-19 pandemic: An overview of the reports","volume":"41","author":"Rahimi","year":"2020","journal-title":"Neurol Sci"},{"key":"R6-44-20240828","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: The early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"key":"R7-44-20240828","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19: A newly emerging post-infectious complication","volume":"267","author":"Webb","year":"2020","journal-title":"J Neurol"},{"key":"R8-44-20240828","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fneur.2020.00909","article-title":"COVID-19 and Guillain\u2013Barr\u00e9 syndrome: A case report and review of literature","volume":"11","author":"Zito","year":"2020","journal-title":"Front Neurol"},{"key":"R9-44-20240828","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2454_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:29:12Z","timestamp":1786735752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2454_20"}},"subtitle":["Guillain\u2013Barre syndrome"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2454_20","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}